169 related articles for article (PubMed ID: 24372004)
1. Effect of CYP1A2 polymorphism on the pharmacokinetics of agomelatine in Chinese healthy male volunteers.
Song L; Du Q; Jiang X; Wang L
J Clin Pharm Ther; 2014 Apr; 39(2):204-9. PubMed ID: 24372004
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics.
Saiz-Rodríguez M; Ochoa D; Belmonte C; Román M; Vieira de Lara D; Zubiaur P; Koller D; Mejía G; Abad-Santos F
J Psychopharmacol; 2019 Apr; 33(4):522-531. PubMed ID: 30789308
[TBL] [Abstract][Full Text] [Related]
3. Effect of the P450 oxidoreductase 28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers.
Zhang JJ; Zhang H; Ding XL; Ma S; Miao LY
Eur J Clin Pharmacol; 2013 Apr; 69(4):807-12. PubMed ID: 23097010
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Eltrombopag in Healthy Chinese Subjects and Effect of Sex and Genetic Polymorphism on its Pharmacokinetic and Pharmacodynamic Variability.
Chen J; Xu Y; Lou H; Jiang B; Shao R; Yang D; Hu Y; Ruan Z
Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):427-436. PubMed ID: 33779967
[TBL] [Abstract][Full Text] [Related]
5. CYP1A2 polymorphism may contribute to agomelatine-induced acute liver injury: Case report and review of the literature.
Wang S; Xu Q; Qu K; Wang J; Zhou Z
Medicine (Baltimore); 2021 Nov; 100(45):e27736. PubMed ID: 34766583
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence and Pharmacokinetic Profiles of Agomelatine 25-mg Tablets in Healthy Chinese Subjects: A Four-Way Replicate Crossover Study Demonstrating High Intra- and Inter-Individual Variations.
Li C; Xu J; Zheng Y; Chen G; Wang J; Ma L; Qiao Y; Niu J; Wu M; Zhang H; Li X; Chen H; Zhu X; Liu C; Ding Y
Chem Pharm Bull (Tokyo); 2017 Jun; 65(6):524-529. PubMed ID: 28392509
[TBL] [Abstract][Full Text] [Related]
7. Current evidence on the relationship between three polymorphisms in the CYP1A2 gene and the risk of cancer.
Zhenzhen L; Xianghua L; Ning S; Zhan G; Chuanchuan R; Jie L
Eur J Cancer Prev; 2013 Nov; 22(6):607-19. PubMed ID: 23462460
[TBL] [Abstract][Full Text] [Related]
8. No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects.
Guo X; Chen XP; Cheng ZN; Luo X; Guo R; Chen L; Chen J; Chen B; Peng J; Li YJ
Clin Chem Lab Med; 2009; 47(1):38-43. PubMed ID: 19072027
[TBL] [Abstract][Full Text] [Related]
9. Inter- and Intra-individual Variability in the Pharmacokinetics of Agomelatine Tablets in Chinese Healthy Male Subjects.
Wang XL; Du AH; Zhang D; Meng LJ; Liu M; Zhang LN; Zhao HN; Liu HC
Drug Res (Stuttg); 2015 Oct; 65(10):552-4. PubMed ID: 25383559
[TBL] [Abstract][Full Text] [Related]
10. Associations between CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluric acid/theophylline ratios.
Yoon Y; Park HD; Park KU; Kim JQ; Chang YS; Song J
Eur J Clin Pharmacol; 2006 Aug; 62(8):627-31. PubMed ID: 16841220
[TBL] [Abstract][Full Text] [Related]
11. Four polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene and lung cancer risk: a meta-analysis.
Bu ZB; Ye M; Cheng Y; Wu WZ
Asian Pac J Cancer Prev; 2014; 15(14):5673-9. PubMed ID: 25081684
[TBL] [Abstract][Full Text] [Related]
12. Determinants of gefitinib pharmacokinetics in healthy Chinese male subjects: A pharmacogenomic study of cytochrome p450 enzymes and transporters.
Wan Z; Guo L; Li P; Zhao Z; Xu B; Ren L; Yan Y; Liu H; Zhang Y; Liu L
J Clin Pharm Ther; 2020 Oct; 45(5):1159-1167. PubMed ID: 32562509
[TBL] [Abstract][Full Text] [Related]
13. Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations.
Qi GZ; Zhang ZY; Wang X; Yin SJ; Lou YQ; Zhang GL
J Clin Pharm Ther; 2016 Feb; 41(1):84-91. PubMed ID: 26763760
[TBL] [Abstract][Full Text] [Related]
14. CYP1A2 rs762551 polymorphism and risk for amyotrophic lateral sclerosis.
Siokas V; Karampinis E; Aloizou AM; Mentis AA; Liakos P; Papadimitriou D; Liampas I; Nasios G; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
Neurol Sci; 2021 Jan; 42(1):175-182. PubMed ID: 32592103
[TBL] [Abstract][Full Text] [Related]
15. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics.
Zhou Q; Ruan ZR; Yuan H; Xu DH; Zeng S
Pharmazie; 2013 Feb; 68(2):129-34. PubMed ID: 23469685
[TBL] [Abstract][Full Text] [Related]
16. Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers.
Wang L; Hu Z; Deng X; Wang Y; Zhang Z; Cheng ZN
Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):257-63. PubMed ID: 23167834
[TBL] [Abstract][Full Text] [Related]
17. Effects of the CYP oxidoreductase Ala503Val polymorphism on CYP3A activity in vivo: a randomized, open-label, crossover study in healthy Chinese men.
Yang G; Fu Z; Chen X; Yuan H; Yang H; Huang Y; Ouyang D; Tan Z; Tan H; Huang Z; Zhou H
Clin Ther; 2011 Dec; 33(12):2060-70. PubMed ID: 22177374
[TBL] [Abstract][Full Text] [Related]
18. Functional single-nucleotide polymorphism (rs762551) in CYP1A2 gene affects white coffee intake in healthy 20- to 40-year-old adults.
Nikrandt G; Mikolajczyk-Stecyna J; Mlodzik-Czyzewska M; Chmurzynska A
Nutr Res; 2022 Sep; 105():77-81. PubMed ID: 35905656
[TBL] [Abstract][Full Text] [Related]
19. A semiphysiological population pharmacokinetic model of agomelatine and its metabolites in Chinese healthy volunteers.
Xie F; Vermeulen A; Colin P; Cheng Z
Br J Clin Pharmacol; 2019 May; 85(5):1003-1014. PubMed ID: 30761579
[TBL] [Abstract][Full Text] [Related]
20. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]